Skip to main content
Published Online:https://doi.org/10.3928/0090-4481-19980701-11
First page image

  • 1. Cher, RT, Rasnigi SC, Mullen JR, er al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994; 12:542- 5 50.

    Google Scholar
  • 2. Duelos P. Surveillance des effets secondaires de lu vaccination. Santé. 1994:4:21 5220.

    Google Scholar
  • 3. Gangarow EJ, Calaíta AM. WoKe CR, Chen RT, Phillips LM, Caligaro« RE, Miller E. Impact ot thé jnti-whole- cell pertussis vaccine movements. Lancet. 1 997 ;35 1:3 56-361.

    Google Scholar
  • 4. Galaika AM, Rohenson SE. Oblapenko GP. Resurgence of diphtheria. Eur I Epdemioi. 1995:11:95-105.

    Google Scholar
  • 5. Wilson GS. The hazard* <if immunization. London: Athlone Press. 1967.

    Google Scholar
  • 6. Schumachet W. Legal/ethical aspects of vaccinations. Dec Bio! Suini 1979:43:43543R.

    Google Scholar
  • 7. Penmsi E. Monkey virus DNA found in rate human cancers. Sdente. 1997:275:748749.

    Google Scholar
  • 8. Food and Drug Admin ? s trat inn. Bovine-derived materials: Agency letters to manufacturers oí PDA-regulated products. Fedirai Riguifr. 1994; 59: 445 9 1-44 5 94.

    Google Scholar
  • 9. Mathieu M, ed. Biologic Development. A Regulators Own«». W.iltham, MA. Paraxel, 1993.

    Google Scholar
  • 10. Neustadt RE, Finchere HV TVit Su™ FIu Affair- Üecisiun-MoJting on a S!ip|*r> Disease. Washington, DC: US Government Printing Office. 1978.

    Google Scholar
  • 11. Lloyd JC, Chen RT. The Urnhe mumps vaccine: lessons in adverse event surveillance and response. Pharmeioep\dem\olog)· and Drug Saferj. 1996;5:S45. Abstract.

    Google Scholar
  • 12. Kimura M, Kuno-Sakai H, Yamazaki S, et al. Adverse events associated with MMR vaccines in Japan. ACBI Pittdiamca Jupomco. 1996:38:205-211.

    Google Scholar
  • 13. HowsonCP, Howe CJ, Finchere HV, eds. Institute of Medicine. Adverse effects of pertussis and rubella vaccines: A report of the Committee to Review lhe Adverse Consequences or Pertussis and Rubella Vaccines. Washington, Dt:: National Academy Press, 1991.

    Google Scholar
  • 14. Stratton KR, Howe CJ, Johnsion RB, eds. Adverse events associated with childhoud vaccines; Evidence bearing on causality. Washington, DC; National Academy Press, 1994.

    Google Scholar
  • 15. Chen RT. Special methodological issues in pharmacoepidermology studies of vaccine safety. In: Strom BL. ed. Pharmaciiepiiíemialjgy. Susses; John Wiley & Sons, 1994:581-594

    Google Scholar
  • 16. Fine PEM, Chen RT. Confounding in studies ut adverse reactions tu vaccines. Am J Epidemia. 1992^136:121-135.

    Google Scholar
  • 17. Rothman KJ1 ed. Cawífll inference. Chestnut HiH. MA: Epidemiology Resources, Inc., I98R

    Google Scholar
  • 18. Famngton CP, Pugh S, Calville A, et al. A new method for active surveillance of adverse events lrom d i phther ? a/tetan us/pertussis .ind measles/niumps/riihella vaccines. Lancet. 1995 ;345: 567-569.

    Google Scholar
  • 19. Ellenberg SS, Chen RT. The complicated task of monitoring vaccine safety. PuMrc Health Reports. 1997:1 12:10-20.

    Google Scholar
  • 20. Moms R, Halperin S, Dery P, et al. IMPACT monitoring network, -a better mousetrap. Can ; infecí Dis. 1993:4:194-195.

    Google Scholar
  • 21. Roberts JD, Roas LL, Poffcnroth LA. et al. Surveillance ni vacci ne- related adverse events in the first year of life: A Manitoba cohort study. ] Clin Efiülemiol. 1996:49:51-58.

    Google Scholar
  • 22. Chen RT, Classer J, Rhodes P1 et .il. The Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States. Pediatrics. 1997:9*765-775.

    Google Scholar
  • 23. Rosenthal KL. McVittie LD. The clinical testing of preventive vaccines. In: Mathieu M, ed. Biologic Detviipmeni A Regularon Oucniew. Waltham. MA: Paraxel. 1993:119-130.

    Google Scholar
  • 24. Pinichieto ME. Acellular pertussis vaccines: towards an improved safety profile. Drug Experience. 1996;15:31 1-324.

    Google Scholar
  • 25. Global Programme on Vaccines and Immunization. Quality: the first consideration. Geneva: WHO/GPV/SAGE.97/WP.03.

    Google Scholar
  • 26. Steinhotf MC, Reed GF, l\cket MD. et al. A randomized comparison of reactogemcity and immunogenicity of two whole-cell pertussis vaccines. Pediatrici. 1995:5567-570.

    Google Scholar
  • 21. Nm MT, Rhodes P, Salive M. Lively T. Davis DM, Black S, et al. Comparative safety ot two recumhnant hepatitis b vaccines in children: dat.i from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSDlJ CIm Epidemici. 1998: In press.

    Google Scholar
  • 26. Baratt LJ, Codv CL. Cherrv JD. DTP-associared reactions: an analvsis Sy mjecnon sire, manufacturer, piior reactions, and dose. Pediatrics. 1 984:73: 3 1-36.

    Google Scholar
  • 29. Rastogi SC, ed. International Workshop: Harmonization ot Reporting of Adverse Events Fullowine Vaccination R«k ville, MD- RTVCBER. 1993.

    Google Scholar
  • 30. Wiholm BE. Olsoon S, Moore N. Wood S. Sr>intanenus reporting svsiems outside the U.S. In: Strom BL. ed. PhormacoeptáenuoL·^, . Sussex: John Wi ley 6t Sons. 1994:159-155.

    Google Scholar
  • 31. Centers fur Disease Control. National Childhood Vaccine Injury Act: Requirement tor Permanent Vaccination Records and fur Reporting of Selected Events after Vaccination. MMVITR. 1988:37:197-200.

    Google Scholar
  • 32. Steiler HC, Mullen JR. Brennan JP, Livengood JR, Orenstein WA, Hinman AR. Monitoring system tor adverse events following immuniiation. Vaccine. 1987,5:169174.

    Google Scholar
  • 33. Braun MM. Ellenberg SS. Descriptive epidemiology of adverse events after immvineat ion: reports to the Vaccine Adverse Event Reporting System (VAERSI. 19911994- .J Pidiair. 1997:131:529-535.

    Google Scholar
  • 34. Femchel GM. Lane DA, Livengood JR, Hotwiti SJ, Menkes JH. Schnarr: JF. Adverse events following immunization: assessing probability of causation. Pedían Neural. 1989:5:287-290.

    Google Scholar
  • 35. Wassilak SGF, Sokhey J. Monitoring of adverse events following immunization in the Expanded Programme on Immunization. World Health Organ i :a u on. 1991;WHO/EPl/GEN/91.2:l-29.

    Google Scholar
  • 36. Kramer MS, Lane DA. Causal propositions in clinical research and practice. J CIm Efndemiol. 1 99 2 ;4 5:6 39-649.

    Google Scholar
  • 37. Manner WK. Compensation programs for v ace i ne- related injury ahroad: a comparative analysis. Saint Louis Unnjerîirv Lan· Journal- 1987:31:599-654.

    Google Scholar
  • 38. Forsey T. Mawn JA, Yates PJ, Bentl'y ML, Minor PD. Differentiation of vaccine and wild mumps viruses using the polymetase chain reaction and dideoxinucleohde. } Gen Virai. 1990:71:987-990.

    Google Scholar
  • 39. HendersonDA, Wirte JJ, Morris L, Langmuir AD. Paralytic disease associated with oral potio vaccines. JAMA. 1964;190:1 53-160.

    Google Scholar
  • 40. Ray WA, Griffin MR. Confounding in studies of adverse reactions to vaccines (lettei). AmJEpiDbwJ- 1994:139:229.

    Google Scholar
  • 41. Davis R. Vadheim C, Black S, et al. Immuniiation tracking systems: experience or the CDC Vaccine Safety Datalink sites. HMO Practice. 1997:1 1:13-17.

    Google Scholar
  • 42. Black SB. Shmefield HR, and the Northern California Permanente Medical Care Program Department of Pediatrics Vaccine Study Group. b-CAPSA I Haemophilus influenzae, type b capsular polysaccharide vaccine safety. Pediatrics. 1987:79:321325.

    Google Scholar
  • 43. Williams JC. Goldenthal KL, Bums DL, Lewis BP Jr. eds. Combined vaccines and simultaneous administration: current issues and perspective. New York: New York Academy of Science. 1995.

    Google Scholar
  • 44. Hinman AR, Orenstein WA. Public health considerations. In: Plotkin SA. Mumm« EA, cd.v '.',«(i?«. Philadelphia: WB Saurders: !994:903-932

    Google Scholar
  • 45. Evans G. Vaccine liability· and safely: a progress repon. Pedían Infecí Dis ]. 1996:15:477-478.

    Google Scholar
  • 46. Walker AM, Jick H, Petera DR. et al. Neurologic events lullowinjj Jiphthenatetanus-pertussis immuniiation. Pediatrici. 1988:81:545-349.

    Google Scholar
  • 47. Griffin MR, Ray WA, Mortimer EA, el al. Risk of seizures and encephalopathy after immuniiation with the diphiheria-tetanus-pertussii vaccine. JAMA. 1 990-.26Î: 1641-1645.

    Google Scholar
  • 48. Fine PEM. Methodological issues in the evaluation and mon i lining of vaccine satety. Ann NY Acad Sci. 1995;754:30l)-308.

    Google Scholar
  • 49. Watson JC, Petet G. Generai immun cation practices. In: Plorkin SA, Otienstein WA (eds). Vaccines (3rd ed.i. Philadelphia: WB Saunders, 1998. In Press.

    Google Scholar
  • 50. American Academy of Pediatrics. Active immunization. In: Peter G, ed. I997 Redhook- Repon of die Committee on Infectious Diseases. 24th ed. Elk Giove Village, IL: American Academy of Pediatrics, 1997:4-36.

    Google Scholar
  • 51. US Department of Health and Human Services, Public Health Service, CDC. Vaccine management tec ommendat ions for handling and storage of selected hiologicali. March 1991.

    Google Scholar
  • 52. U.S. Department of Health and Human Services, Public Health service, CDC. Guidelines for vaccine packing and shipping. January 1997.

    Google Scholar
  • 53. Weniger BG, Chen RT, jacobsen SH, Scwell EG. Deuson R, Livengood JR. et al. Addressing the challenges to immuniiation practice with an economic algorithm for vaccine selection. Vaccine. 1998 (in press).

    Google Scholar
  • 54. Zaffran M, Lloyd J, Clements J, Stilwell B. A drive to safer inactions. Geneva: WHO/GPV/SAGE.97/WP.05, 1997.

    Google Scholar
  • 55. Orenstein WA. DTP vaccine litigation, 1988. Am } Dis Child. 1990;144:517.

    Google Scholar
  • 56. Institute of Medicmc: Liahility for the production and sale of vaccine. In: Vaccine supply and rnnauation. Washington. DC: National Academy Press, 1985;85-122.

    Google Scholar
  • 57. Offit PM, Bell LM. What every parent should know ahont vaccines. New Yotk: Simon & Schuster Macmillan Company, 1998:1.

    Google Scholar
  • 58. Freed GL, Katz SL, Clark SJ. Safety of vaccinations miss America, the media, and public health. JAMA. 1996:276:1869-1872,1917-1918.

    Google Scholar
  • 59. Instilule of Medicine: Risk Communicalion and Vaccination. Workshop summary. Washington, DC: National Academy Press, 1997.

    Google Scholar
  • 60. National Research Council, improvmg risk communication. Washington, DC: Nalional Academy Press, 1989.

    Google Scholar
  • 61 . Fischhoff B, Bostrrim A, Jacobs-Qiiadrel M. Risk perceptions and cotnmunicaiion. Annual Review of Public Health. 1993; 14:182-203.

    Google Scholar
  • 62. Hihhs BF, Wolfe S, Chen RT. Interner Weh page perceptions of vaccine pharmacoepidemiology research: An analysis of vaccine safety concerns. Abstract 129. Abstracts of the 13th International Conference on Pharmacoepidemiology. Walt Disney Wotld, Florida: August 24-27, 1997. Phannacoepidemiolog) and Drug Safety. 1997;6(suppl2):S60.

    Google Scholar
  • 63. Mesiaros JR, Asch DA, Fiaron J, Hershey JC, Kunreuther H, Schwärt z -Buiaglo J. Cognitive processes and the decisions of some parents to forego pertussis vaccination tor their children. J Clin Epioemml. 1 996:49:697-703 .

    Google Scholar
  • 64 Hance BJ, Chess C, Sandman G. Jndustr} nsk communication manual. Chelsea. Ml: Lewis Publishers, 1990.

    Google Scholar
  • 65 Trie Nnnonal Childhood Vaccine Imurv Act of 1986, at Secnon 2125 oi ihe Public Health Service Act as codified at 42 U.S.C. § 300aa-(Suppl.l987>.

    Google Scholar
  • 66. O'Connor AM, Pennie RA, Dales RE. Framing effects on expectations, decisions, and side effects experienced: The case of influenza immunization. J CIm EpidVmiul. 1996:49:1271-1276.

    Google Scholar
  • 67. Baron J. The effect of normative beliefs on anticipated emotions. J Pers Soc Psychol. 1992;63:320-310.

    Google Scholar
  • 68. Bostrom A. Vaccine risk communication: Lessons from risk perceprion, decision making and environmental risk communication research. Rist: Health, Safety & Emmmment. Spring 1997:173-200.

    Google Scholar
  • 69. Bmkm NJ. et al. Epidemiology of pertussis in a developed country1 with low vaccination coverate: the Italian experience. Pcdiarr In/ccf Dis J. 1992; 1 1 :653.

    Google Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×